Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

acquired hemophilia

Known as: acquired haemophilia 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A.
Turoctocog alfa pegol (N8-GP, Novo Nordisk, Bagsværd, Denmark), an extended half-life glycoPEGylated recombinant factor VIII… Expand
Is this relevant?
2015
2015
Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight(®) ) in previously treated patients with severe haemophilia A: interim results of the guardian(™) 2…
M. OZELO,* M. MISGAV,† F. ABDUL KARIM,‡ S. R. LENTZ,§ M. MARTIN-SALCES,¶ I . MATYTSINA,** T. SAUGSTRUP** and E. SANTAGOSTINO… Expand
  • table 1
  • figure 1
Is this relevant?
2013
2013
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A
It is essential to improve therapies for controlling excessive bleeding in patients with haemorrhagic disorders. As activated… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2010
Review
2010
Genetic markers in acquired haemophilia.
Acquired haemophilia (AH) is a rare autoimmune bleeding disorder, which arises as a result of the spontaneous production of… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept.
Acquired hemophilia (AH) is an extremely rare condition in which autoantibodies (inhibitors) against clotting factor VIII induce… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2005
2005
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical…
The safety and efficacy of a full-length sucrose-formulated recombinant factor VIII product (rFVIII-FS; Kogenate FS; Kogenate… Expand
Is this relevant?
2003
2003
Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report.
Multicentric Castleman's Disease (MCD) is an atypical lymphoproliferative disorder, related to human herpesvirus 8 (HHV-8… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
Radiological and orthopaedic outcome in severe and moderate haemophilia A and B patients undergoing long-term prophylactic… Expand
Is this relevant?
1995
1995
Severe haemophilia A in a female resulting from two de novo factor VIII mutations.
A 2-year-old girl is described with severe haemophilia A (factor VIII: C < 0.01 units/ml). Both of her parents were… Expand
Is this relevant?
1991
1991
Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene
In an attempt to replace the existing, DNA-based, 50% effective, carrier and prenatal diagnoses of haemophilia A with the 100… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE